VKH
CLRB icon

Virtu KCG Holdings’s Cellectar Biosciences CLRB Stock Holding History

Virtu KCG Holdings’s Portfolio CLRB Stock Details CLRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$106K Buy
22
+11
+100% +$60.3K ﹤0.01% 2397
2017
Q1 		$77K Sell
11
-23
-68% -$137K ﹤0.01% 2748
2016
Q4 		$125K Buy
+34
New +$184K ﹤0.01% 2824
2016
Q1 		– Sell
-1
Closed -$13K – 2878
2015
Q4 		$13K Buy
+1
New +$42.5K ﹤0.01% 3348
2015
Q1 		– Hold
0
– -$44K – 3221
2014
Q4 		– Hold
0
– – – 3470

Other funds holding CLRB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

Virtu KCG Holdings's CLRB Position: Q2 2017 in Review

Virtu KCG Holdings increased its Cellectar Biosciences (CLRB) stake by 100% in Q2 2017, buying an estimated $60.3K and bringing the position to 22 shares worth $106K. The position accounts for ﹤0.01% of the portfolio, ranked #2397.

Virtu KCG Holdings first reported a position in CLRB in Q4 2015 and has held it in 4 quarters since. The position peaked at $125K in Q4 2016. 8 funds tracked by Wall St. Rank hold CLRB as of Q2 2017.

  • Virtu KCG Holdings held 22 shares of Cellectar Biosciences worth $106K as of Q2 2017.
  • Virtu KCG Holdings bought 11 Cellectar Biosciences shares in Q2 2017, an estimated $60.3K.
  • Cellectar Biosciences made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2397 holding.
  • Virtu KCG Holdings first reported a position in Cellectar Biosciences in Q4 2015 and has held it in 4 quarters since.
  • Virtu KCG Holdings's Cellectar Biosciences position peaked at $125K in Q4 2016.
  • 8 funds tracked by Wall St. Rank held Cellectar Biosciences as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.